Headquartered in Indianapolis, IN Fiscal year ends December NYSE: ELV elevancehealth.com
Elevance Health, Inc. (NYSE: ELV) is a diversified health services company that serves approximately 104 million consumers through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions. The company operates through four reportable segments: Health Benefits (encompassing Individual/ACA, Employer Group risk-based and fee-based, BlueCard, Medicare, Medicaid, and Federal Employee Program businesses), CarelonRx (pharmacy services including specialty pharmacy), Carelon Services (healthcare services and risk-based care solutions), and Corporate & Other. As of June 30, 2026, Elevance Health had approximately 44.9 million medical members. The company is a Blue Cross Blue Shield licensee and is focused on medical cost management, member experience, provider connectivity, operating efficiency, and value-based care through its Carelon platform. Updated
Elevance's CFO cut roughly a third of his reported common stock in one day, selling 10,584 shares for about $4.65 million into prices as high as $447.19. No 10b5-1 plan is flagged, which makes this a discretionary exit by the person who knows the Medicare Advantage cost math best.
The managed-care insurer heads into today's earnings report already on the back foot, down 4.38% on the day. That slide sets a low bar for how the report lands.
Elevance reports before the open at 6:00 AM ET with four straight EPS beats behind it, the last one topping estimates by 20.6%. Consensus sits at $4.69 on $49.16 billion in revenue, and Medicare Advantage cost trends are the line that decides how insurers trade today.
Elevance Health just set a new 52-week high at $425.27, a full round trip from its March low.
UnitedHealth has shed members, slipped 10% in three months, and closed lower on a beat-and-raise quarter. Now a major Wall Street firm is calling for 40% gains, and its argument centers on…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) shares are up 4% to $395.19 after the health insurer topped Q3 2026 profit estimates and raised its full-year outlook. The beat came on the…
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding…
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped…
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
Seth Klarman's Baupost Group just revealed its five largest stock positions, and the list includes a little-known industrial distributor posting explosive earnings growth alongside household names bleeding on the front page. Reverse-engineering…
RSP is beating SPY for the first time in years, but two specific signals will determine whether equal-weight strategies keep their edge or surrender it back to the mega-caps before year end.
Your Medicare Advantage plan stays active on paper, but the hospital you have used for decades can quietly vanish from your network before your next appointment, and the protections meant to help…
Michael Williams UnitedHealth Group (NYSE:UNH | UNH Price Prediction) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of…
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each…
Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by Gabelli Funds that has quietly paid quarterly distributions for more than 14…
Elevance Health (NYSE:ELV | ELV Price Prediction) stock surged this week after the Centers for Medicare & Medicaid Services finalized a 2.48% Medicare Advantage payment rate increase for 2027, coming in above…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock is up nearly 11% today, moving from $281.36 to $311 and change, as the managed care sector stages a powerful relief rally. Humana (NYSE:HUM)…
The Centers for Medicare & Medicaid Services (CMS) finalized the 2027 Medicare Advantage payment rate at a +2.48% net average increase, well above the +0.09% proposed in January and above the roughly…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock got a meaningful vote of confidence from Bank of America on Tuesday, as analyst Kevin Fischbeck raised the firm’s price target to $337 from…
Elevance Health, Inc. (NYSE: ELV) is a diversified health services company that serves approximately 104 million consumers through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
24/7 Wall St.'s 12-month price target for ELV is $636.76, rated Buy. The Wall Street consensus target is $482.38. ELV price prediction →
